Nordea Investment Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.11M | Sell |
|
|||||
|
2022
Q4 | $2.03M | Sell |
|
|||||
|
2022
Q3 | $3.43M | Buy |
|
|||||
|
2022
Q2 | $2.74M | Buy |
|
|||||
|
2022
Q1 | $3.94M | Buy |
|
|||||
|
2021
Q4 | $4.84M | Sell |
|
|||||
|
2021
Q3 | $5.84M | Sell |
|
|||||
|
2021
Q2 | $7.64M | Buy |
|
|||||
|
2021
Q1 | $7.16M | Buy |
|
|||||
|
2020
Q4 | $8.75M | Buy |
|
|||||
|
2020
Q3 | $3.28M | Sell |
|
|||||
|
2020
Q2 | $5.83M | Buy |
|
|||||
|
2020
Q1 | $2.11M | Buy |
|
|||||
|
2019
Q4 | $2.63M | Buy |
|
|||||
|
2019
Q3 | $2.74M | Buy |
|
|||||
|
2019
Q2 | $3.21M | Sell |
|
|||||
|
2019
Q1 | $2.95M | Sell |
|
|||||
|
2018
Q4 | $3.63M | Sell |
|
|||||
|
2018
Q3 | $5.39M | Buy |
|
|||||
|
2018
Q2 | $2.73M | Buy |
|
|||||
|
2018
Q1 | $2.29M | Buy |
|